HOME >> BIOLOGY >> NEWS
Improved medical treatment of serious heart problems focus of UH-led group

HOUSTON, Feb. 16, 2004 Suncica Canic, University of Houston mathematics professor, and her research group are presenting new findings related to the medical treatment of two serious heart problems at the American Association for the Advancement of Science (AAAS) annual meeting in Seattle at 8 a.m. P.S.T., Monday, Feb. 16.

The main goal of her work is to help cardiologists gain deeper insight into the behavior of vascular prostheses, called stents, used in the treatment of aortic abdominal aneurysm (AAA) and in coronary angioplasty.

The project is the result of an interdisciplinary collaboration Canic initiated between experts in cardiology, mathematics, biology, engineering and scientific computing to work on several problems related to the medical treatment of AAA and the treatment of coronary artery disease (CAD).

"Mathematical equations can be used to describe various physical, biological and physiological phenomena," Canic said. "Interaction between mathematics, engineering, biology and medicine has existed for a long time, but it has been only recently that state-of-the-art computer technology and scientific computing enabled true collaboration and full benefits to all the involved disciplines, as well as now bringing it to the human application stage. This is the first time in history that many complicated functions of the human body can not only be approximated with complicated mathematical equations, but also that solutions to those equations that cannot be found by hand can be calculated and visualized using super powerful computers."

One of the main focuses of the AAAS conference's "Symposium on Optimal Stent Design for Cardiovascular Interventions," led by Canic, will be to address the complicated set of problems in the mathematical and computer simulation of various cardiovascular diseases. In addition to Canic, who is the founder of this group, the other scientists involved in this interdisciplinary endeavor i
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
16-Feb-2004


Page: 1 2 3

Related biology news :

1. Improved nutrition could reduce malaria burden worldwide
2. Improved nutrition could prevent more than half of the worlds child deaths annually
3. Improved crop production and fewer greenhouse gases
4. Improved estimates of population extinction risk (Harding and McNamara)
5. Improved guidance systems for missiles will reduce collateral damage
6. Bone Marrow Transplants May Be Improved Thanks To Discovery Of Mechanism Underlying Human Stem Cell Migration
7. Virginia Tech Research Group Presents Improved Dental Materials
8. Perfect Powders For Improved Implants
9. Improved Oxygen Bath To Heal Wounds, Lessen Number Of Amputations: Sandia To Sign Agreement With Numotech To Help Create Home-Use Healing Facility
10. New Tuberculosis Vaccine Candidate Developed: Improved Delivery Of Antigens By Current Vaccine BCG (Bacille Calmette-Gurin)
11. New Company To Turn UNC-CH, Army Inventions Into Improved Vaccines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/13/2017)... According to a new market research report "Consumer ... Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - ... to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
Breaking Biology Technology:
Cached News: